Interaction of EGFR with phospholipase C-gamma
Browse our antibodies, ELISA kits and proteins related EGFR and its interaction with phospholipase C-gamma.Browse our antibodies, ELISA kits and proteins related EGFR and its interaction with phospholipase C-gamma.
Adenlyate Cyclases
ADCY1 (Adenylate Cyclase 1 (Brain)):
ADCY2 (Adenylate Cyclase 2 (Brain)):
ADCY3 (Adenylate Cyclase 3):
ADCY4 (Adenylate Cyclase 4):
ADCY5 (Adenylate Cyclase 5):
ADCY6 (Adenylate Cyclase 6):
Adcy7 - ADCY7:
ADCY8 (Adenylate Cyclase 8 (Brain)):
ADCY9 (Adenylate Cyclase 9):
Calmodulin
CAMK4 (Calcium/calmodulin-Dependent Protein Kinase IV):
Calm1 - Calmodulin 1:
Calm2 - Calmodulin 2:
CALM3 - Calmodulin 3:
CALM3 - Calmodulin 3:
Phosphodiesterase/lipase
PDE1A (Phosphodiesterase 1A):
PDE1B (phosphodiesterase 1B, Calmodulin-Dependent):
PDE1C (phosphodiesterase 1C, Calmodulin-Dependent 70kDa):
PIPLC - Phosphoinositide-Specific phospholipase C:
PLC (Phospholipase C):
PLCG1 - Phospholipase C gamma 1:
Protein Kinase
PROKR1 - Prokineticin Receptor 1:
PROKR2 - Prokineticin Receptor 2:
PRKACA (Protein Kinase A, alpha):
PKC (Protein Kinase C):
PKCa - PKC alpha:
PKCd - PKC delta:
PRKCE - PKC epsilon:
PRKCG - PKC gamma:
PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta):
PRKACG (Protein Kinase, CAMP-Dependent, Catalytic, gamma):
PRKAR1A (Protein Kinase, CAMP-Dependent, Regulatory, Type I, alpha (Tissue Specific Extinguisher 1)):
PRKAR1B (Protein Kinase, CAMP-Dependent, Regulatory, Type I, beta):
PRKAR2A (Protein Kinase, CAMP-Dependent, Regulatory, Type II, alpha):
PRKAR2B (Protein Kinase, CAMP-Dependent, Regulatory, Type II, beta):
RPS6KB1 (Ribosomal Protein S6 Kinase, 70kDa, Polypeptide 1):
Misc
ADRBK1 - GRK2:
ADRB1 (Adrenergic, beta-1-, Receptor):
CREB1 (cAMP Responsive Element Binding Protein 1):
EGF (Epidermal Growth Factor):
EGFR (Epidermal Growth Factor Receptor):
ITP-R83A - IP3 Receptor:
ITPR1 (Inositol 1,4,5-Trisphosphate Receptor, Type 1):
ITPR2 (Inositol 1,4,5-Trisphosphate Receptor, Type 2):
ITPR3 (Inositol 1,4,5-Trisphosphate Receptor, Type 3):
Vous êtes ici:
